Coconut Oil in Cardiovascular Disease
HCCO
The Effect of Extra Virgin Coconut Oil Treatment Nutritional Associated With Data Anthropometric and Lipid Profile in Patients With Chronic Heart Disease
1 other identifier
interventional
116
1 country
1
Brief Summary
The purpose of this study is to evaluate the supplementation with extra virgin of coconut oil combined with a nutritional counseling in reducing anthropometry and improves the lipid profile in patients with chronic coronary disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 8, 2013
CompletedFirst Posted
Study publicly available on registry
October 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedOctober 14, 2013
October 1, 2013
2.2 years
October 8, 2013
October 10, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anthropometry
To evaluate the effect of extra virgin coconut oil in the improvement of weight, waist circumference and neck circumference in patients with chronic coronary artery disease
3 months
Secondary Outcomes (2)
Lipid profile
3 months
Quality of the diet
3 months
Study Arms (2)
Nutritional treatment
OTHERAll patients received an individualized diet plan and balanced. The diet was calculated according to the nutritional status and the protein 15-20% of total energy value, lipids 25-30% of daily energy intake and carbohydrate 50-60% of of total energy value
extra virgim coconut oil group
EXPERIMENTALOil from coconuts (cocos nucifera L.) contains a high proportion of medium chain fatty acids, principally the lauric acid (12:0), in proportions that range from 45 to 50%
Interventions
Patients were followed for 6 months with dietary treatment. Beginning supplementation with coconut oil extra virgin from the third month of intervention nutrition. Coconut oil was consumed neat or added to fruit.
Patients were instructed to follow the dietary treatment for 6 months
Eligibility Criteria
You may qualify if:
- Presenting chronic coronary artery disease (myocardial infarction and/or stable angina
You may not qualify if:
- angioplasty and/or coronary artery bypass grafting and previous cardiovascular event \<6 months and those who had chronic renal failure with creatinine values\> the 2mg/dl and liver disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional do Coração
Rio de Janeiro, Rio de Janeiro, 22240-002, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diuli A Cardoso, Ms
Universidade Federal do Rio de Janeiro
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- researcher official
Study Record Dates
First Submitted
October 8, 2013
First Posted
October 14, 2013
Study Start
January 1, 2012
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
October 14, 2013
Record last verified: 2013-10